Skeletal Muscles Injury Related to SARS-CoV-2 Infection: A Case Report
Keywords:neurological manifestation, skeletal muscle injury, myalgia, renal damage, SARS-CoV-2, case report
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a disease related to coronavirus (SARS-CoV-2) which is categorized as Nidovirales order, family beta-coronaviridae. Coronavirus infects mainly the lung as well as other organs out of the lung. Extrapulmonary infection includes neurological infection such as the central nervous system, peripheral nervous system, and musculoskeletal with various symptoms. Recent study reported that 30% of patients had COVID-19-associated skeletal muscle injury.
CASE PRESENTATION: A 78-year-old male with a history of stroke and Type 2 diabetes mellitus came to the emergency department with fever, shortness of breath, decrease of consciousness, joints, and muscles pain. Chest X-ray showed a consolidation in the mid-lower of the lung bilaterally, with prominent bronchovascular markings, polymerase chain reaction COVID-19 result comes out with positive 2 times with 10 days interval. The patient is treated with antibiotics, Avigan, azithromycin, and high-dose intravenous Vitamin C. In the 3rd ward day, the patient still has short of breathiness. However, fever and consciousness improve, but still complaining of pain in the shoulder joint, arm muscles, and knee joint. On the 11th inpatient day, the patient obtains full consciousness; dyspnea improved, no fever, however, the patient still complains of muscle and joint pain. At the end of the inpatient period fever, dyspnea and consciousness seem to be improved; however, the patient still complains of pain in the shoulder joint, arm muscles, and knee joint that not improved with an analgesic. The patient comes back to his home in good condition.
CONCLUSION: COVID-19 patients may develop musculoskeletal symptoms such as skeletal injury or myalgia, and this is our first case of COVID-19 infection complicated with skeletal muscle injury.
Plum Analytics Artifact Widget Block
Xu T, Chen C, Zhu Z, Cui M, Chen C, Dai H, et al. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. Int J Infect Dis. 2020;64:68- 71. https://doi.org/10.1016/j.ijid.2020.03.022 PMid:32179140
World Health Organization. Coronavirus Disease (COVID-19) Outbreak. Geneva: World Health Organization; 2019. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Last accessed on 2020 Oct 07].
Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Victor EA, et al. Neurological and musculoskeletal features of COVID-19: A systematic review and meta-analysis. Front Neurol. 2020;11:687. https://doi.org/10.3389/fneur.2020.00687 PMid:32676052
Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020;15(1):178. https://doi.org/10.1186/s13018-020-01702-w PMid:32423471
Dewi VT, Laksmidewi AA, Sudiarini KA. Clinical manifestation and pathogenesis of nervous system involvement in severe acute respiratory syndrome Coronavirus-2 infection. Asian J Pharm Clin Res. 2020;13(10):23-8. https://doi.org/10.22159/ajpcr.2020.v13i10.39006
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J Med Virol. 2020;92(7):797-806. https://doi.org/10.1002/jmv.25783 PMid:32198776
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683- 90. https://doi.org/10.1001/jamaneurol.2020.1127 PMid:32275288
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/ S0140-6736(20)30183-5
Kucuk A, Cure MC, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol. 2020;39(7):2103-4. https://doi.org/10.1007/ s10067-020-05178-1 PMid:32458242
Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, Senel ME, et al. 2019 novel Coronavirus (COVID-19) outbreak: A review of the current literature. Eurasian J Med Oncol. 2020;4(1):1-7.
Cure E, Cure MC. Comment on organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis
of COVID-19. J Med Virol. 2020;92(9):1423-4. https://doi.org/10.1002/jmv.25848 PMid:32266994
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. https://doi.org/10.1002/path.1570 PMid:15141377
Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvara S, et al. Chest X-ray in new Coronavirus disease 2019 (COVID- 19) infection: Findings and correlation with clinical outcome. Radiol Med. 2020;125(8):730-7. https://doi.org/10.1007/ s11547-020-01232-9 PMid:32519256
Cleverley J, Piper J, Jones MM. The role of chest radiography in confirming COVID-19 pneumonia. BMJ. 2020;370:m2426. https://doi.org/10.1136/bmj.m2426 PMid:32675083
Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211. PMid:29099763
Dong L, Hu S, Gao J. Discovering drugs to treat Coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. https://doi.org/10.5582/ddt.2020.01012 PMid:32147628
Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, et al. Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering (Beijing). 2020;6(10):1192-8. PMid:32346491
NICE. COVID-19 Rapid Guideline: Antibiotics for Pneumonia in Adults in Hospital; 2020. Available from: https://www.nice.org. uk/terms-and-conditions#notice-ofrights. [Last accessed on 2020 Oct 07].
How to Cite
Copyright (c) 2021 Anak Agung Ayu Putri Laksmidewi, Maria Oktaviany Gabur, Carolin Tiara Lestari Indah (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.